申请人:Ohtake Norikazu
公开号:US20100210637A1
公开(公告)日:2010-08-19
Provided are compounds of a formula (I) and their pharmaceutically-acceptable salts:
wherein X1, X2 and X3 each independently represent N or CH; W represents the following formula (II):
or the following formula (III):
Y represents a group of a formula (IV):
The compounds have a histamine-H3 receptor antagonistic or inverse-agonistic activity and are useful for remedy and/or prevention of obesity, diabetes, hormone secretion disorders, sleep disorders, etc.
提供的是公式(I)的化合物及其药学上可接受的盐:
其中,X1、X2和X3各自独立表示N或CH;W表示以下公式(II):
或以下公式(III):
Y表示以下公式(IV)的基团:
这些化合物具有组胺H3受体拮抗或反拮抗活性,可用于治疗和/或预防肥胖症、糖尿病、激素分泌障碍、睡眠障碍等。